K050665

Substantially Equivalent

N ANTISERA TO HUMAN COMPLEMENT FACTORS (C3C, C4)

Applicant: Dade Behring, Inc.
Product code: CZW
Advisory panel: Immunology
Date received: 2005-03-15
Decision date: 2005-05-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.